Insider · CIK 0002024096
Jose Manuel Otero
Files at LXEO (Lexeo Therapeutics, Inc.). First filing Aug 20, 2025, latest Feb 20, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LXEO: Lexeo Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 28Weak | Lexeo Therapeutics, Inc. | $19k 3,016 shares | -2% | +251% from low-41% from high | |
| 35Weak | Lexeo Therapeutics, Inc. | $6,684 721 shares | -1% | +413% from low-9% from high | |
| 30Weak | Lexeo Therapeutics, Inc. | $6,684 721 shares | -1% | +175% from low-56% from high | |
| 30Weak | Lexeo Therapeutics, Inc. | $19k 2,115 shares | -3% | +435% from low-14% from high | |
| 30Weak | Lexeo Therapeutics, Inc. | $13k 2,848 shares | -5% | +175% from low-56% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | LXEO Lexeo Therapeutics, Inc. | AGrant or award Common Stock | +2,110 | $2.64 | $5,579 | 138,288 | 14 d ago |
| Sep 24, 2026 | LXEO Lexeo Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +54,750 | $0.00 | $0 | 54,750 | 14 d ago |
| Mar 13, 2026 | LXEO Lexeo Therapeutics, Inc. | AGrant or award Common Stock | +5,930 | $2.64 | $16k | 131,390 | Mar 17, 2026 |
| Feb 18, 2026 | LXEO Lexeo Therapeutics, Inc. | SOpen-market sale Common Stock | -3,016 | $6.40 | $19k | 125,460 | Feb 20, 2026 |
| Nov 18, 2025 | LXEO Lexeo Therapeutics, Inc. | SOpen-market sale Common Stock | -721 | $9.27 | $6,684 | 63,476 | Feb 20, 2026 |
| Feb 4, 2026 | LXEO Lexeo Therapeutics, Inc. | AGrant or award Common Stock | +65,000 | $0.00 | $0 | 128,476 | Feb 6, 2026 |
| Feb 4, 2026 | LXEO Lexeo Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +260,000 | $0.00 | $0 | 260,000 | Feb 6, 2026 |
| Aug 18, 2025 | LXEO Lexeo Therapeutics, Inc. | SOpen-market sale Common Stock | -721 | $9.27 | $6,684 | 63,476 | Nov 20, 2025 |
| Oct 15, 2025 | LXEO Lexeo Therapeutics, Inc. | AGrant or award Common Stock | +5,940 | $0.00 | $0 | 66,312 | Oct 17, 2025 |
| Oct 17, 2025 | LXEO Lexeo Therapeutics, Inc. | SOpen-market sale Common Stock | -2,091 | $8.94 | $19k | 64,221 | Oct 17, 2025 |
| Oct 17, 2025 | LXEO Lexeo Therapeutics, Inc. | SOpen-market sale Common Stock | -24 | $9.56 | $229 | 64,197 | Oct 17, 2025 |
| Aug 18, 2025 | LXEO Lexeo Therapeutics, Inc. | SOpen-market sale Common Stock | -2,848 | $4.67 | $13k | 60,372 | Aug 20, 2025 |
| Mar 14, 2025 | LXEO Lexeo Therapeutics, Inc. | AGrant or award Common Stock | +5,720 | $2.61 | $15k | 63,220 | Apr 9, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.